James Crowe

A renowned microbiologist and Ann Scott Carell Professor, Crowe is leading efforts to decipher the human immunome, a vast set of genes and molecular structures critical to fighting disease. Understanding those mechanics could lead to the development of a universal flu vaccine. No guessing required. Read More

James Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, is the 2017 recipient of the Stanley J. Korsmeyer Award given by the American Society for Clinical Investigation (ASCI), one of the nation’s oldest and most respected honor societies for physician-scientists. Read More

Respiratory syncytial virus (RSV) is the major cause of life-threatening viral pneumonia in infants worldwide, yet despite repeated efforts, scientists have been unable to develop an effective vaccine against it. Read More

New discoveries will guide efforts to develop vaccines or antiviral agents for norovirus, the most common cause of infectious diarrhea. Read More

In the latest VUCast: Hear from Ebola survivors helping a Vanderbilt researcher fight the deadly virus; see the high-tech way an art exhibit is bringing VU students face to face with people across the world; and find out which country music star shot his latest video with Mr. Commodore! Watch now. Read More

Vanderbilt researchers have received a five-year, $9 million grant from the National Institutes of Health to design more effective flu vaccines and novel antibody therapies. Read More

U.S. Sen. Lamar Alexander, BA’62, discussed the Ebola epidemic with Vanderbilt physicians during a September visit to campus. Read More